Strong Start to 2025 underpinned by broad-based growth
22/05/25 -"Galenica reported robust growth from January to April 2025, with revenue increasing by 4.7% to CHF 1,314.2 million, outperforming the broader pharmaceutical market. Growth was widespread across ..."
Pages
47
Language
English
Published on
22/05/25
You may also be interested by these reports :
24/05/25
The Q1 25 results of Allegro Group were 3.6-3.8% above the PAP consensus on the EBIT and net income level. The negative aspect was the >85% lower ...
23/05/25
H&M (Reduce; Sweden) continues to face a challenging operating environment in 2025. Following a soft start to the year, back in late March the group ...
22/05/25
Galenica reported robust growth from January to April 2025, with revenue increasing by 4.7% to CHF 1,314.2 million, outperforming the broader ...
22/05/25
We have adopted a more pessimistic view of Travis Perkins’ performance over the near/mid-term. Although we had previously expected the group’s ...